Global Breast Implants Market

Global Breast Implants Market Size, Share, Growth Analysis, By Product Type(Silicone Breast Implants, Saline Breast Implants), By Shape(Round, Anatomical), By Application(Reconstructive Surgery, Cosmetic Surgery), By End user(Cosmetology clinics, Hospitals) - Industry Forecast 2024-2031


Report ID: SQMIG35A2520 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 114 | Figures: 77

Global Breast Implants Market Regional Insights

The leading cause of death worldwide is breast cancer. The global breast implants market's revenue growth is primarily driven by the rising incidence of breast cancer. Due to expanding healthcare spending in the US and a rise in interest in cosmetic surgery operations brought on by the improvement in the country's aesthetics, North America dominated the global market in 2021. In addition, the increased incidence of breast cancer in this area is expected to aid market expansion.

Latin America and the Asia Pacific are anticipated to have profitable growth with a significant CAGR during the projection period. This is a result of developing nations' increased disposable income. Additionally, this area offers a tremendous possibility for low-cost medical tourism treatments. Consequently, it is anticipated that the aforementioned reasons will fuel this region's market expansion.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Breast Implants Market size was valued at USD 1.8 billion in 2019 and is poised to grow from USD 1.97 billion in 2023 to USD 4.5 billion by 2031, growing at a CAGR of 9.4% in the forecast period (2024-2031).

The Global Breast Implants market is highly fragmented due to the strong presence of a large number of players. As a result, the global Breast Implants market has been witnessing the constant entry of new players over the years. In order to sustain the highly competitive environment, existing players differentiate themselves through innovation, quality, and technology. 'Sientra Inc. (US)', 'GC Aesthetics (Ireland)', 'Allergan', 'Mentor Worldwide LLC', 'POLYTECH Health & Aesthetics GmbH', 'Groupe Sebbin SAS', 'Establishment Labs Holdings Inc.', 'Ideal Implant Incorporated', 'HansBiomed Co. Ltd.', 'Shanghai Kangning Medical Supplies Ltd.', 'Guangzhou Wanhe Plastic Materials Co. Ltd.', 'Cereplas', 'Laboratoires Arion', 'G&G Biotechnology Ltd.', 'Guangzhou Silicone Rubber Co. Ltd.', 'Guangzhou Shiji Kangmei Cosmetics Co. Ltd.', 'Implantech Associates Inc.', 'Nagor Limited', 'Arion Laboratories', 'Gurtner GmbH.'

Innovative Product Launches to Fuel Market Growth: It is also anticipated that the introduction of new goods and technology developments that improve vision would accelerate market expansion. The debut of Eve 4.0, a Digital Consultation Solution (DCS) that offers visualization on tools to patients in Europe and Brazil considering breast reconstruction or augmentation, was announced by GC Aesthetics in June 2019. The regional markets' growth is probably going to be boosted by this. The market for breast implants is also growing as a result of increased research into the creation of implants with greater durability. AMSilk GmbH and POLYTECH Health & Aesthetics worked together to launch a clinical trial for the silk-coated breast implant SILKline in Europe in February 2018. The product's predicted acceptance is likely to lead to profitable growth opportunities for the market.

The market for silicone breast implants for breast augmentation and reconstruction is anticipated to rise as a result of new technological developments and enhancements to currently available products. For instance, in May 2021, GC Aesthetics Inc., a maker of silicone breast implants, announced the release of the PERLE, a smooth breast implant with the exclusive surface technology known as BioQ. Therefore, the market is anticipated to expand throughout the projected period as a result of the increased demand for silicone-based breast implants.

The leading cause of death worldwide is breast cancer. The global breast implants market's revenue growth is primarily driven by the rising incidence of breast cancer. Due to expanding healthcare spending in the US and a rise in interest in cosmetic surgery operations brought on by the improvement in the country's aesthetics, North America dominated the global market in 2021. In addition, the increased incidence of breast cancer in this area is expected to aid market expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Breast Implants Market

Product ID: SQMIG35A2520

$5,300
BUY NOW GET FREE SAMPLE